FIXX - Homology Medicines Inc
Close
0.601
-0.019 -3.161%
Share volume: 322,902
Last Updated: Mon 08 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.02
-3.07%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-10 | 2023-03-09 | 2023-05-11 | 2023-08-14 | 2023-11-14 | |
| Assets | ||||||||
| Total Assets | 310.958 M | 284.609 M | 262.651 M | 228.470 M | 197.881 M | 169.337 M | 140.063 M | |
| Current Assets | 262.448 M | 238.440 M | 213.204 M | 181.015 M | 153.583 M | 131.336 M | 106.635 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.322 M | 12.917 M | 12.130 M | 5.989 M | 3.558 M | 4.265 M | 3.023 M | |
| Short Term Investments | 6.322 M | 12.917 M | 12.130 M | 5.989 M | 3.558 M | 4.265 M | 3.023 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 256.126 M | 225.523 M | 201.074 M | 175.026 M | 150.025 M | 127.071 M | 103.298 M | |
| Total Non-current Assets | 48.510 M | 46.169 M | 49.447 M | 47.455 M | 44.298 M | 38.001 M | 33.428 M | |
| Property Plant Equipment | 1.986 M | 1.720 M | 1.415 M | 1.078 M | 1.062 M | 845.000 K | 0.000 | |
| Other Assets | 15.609 M | 15.151 M | 20.900 M | 20.563 M | 20.200 M | 19.837 M | 19.471 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 310.958 M | 284.609 M | 262.651 M | 228.470 M | 197.881 M | 169.337 M | 140.063 M | |
| Total liabilities | 44.704 M | 44.321 M | 53.590 M | 50.492 M | 45.982 M | 49.962 M | 51.852 M | |
| Total current liabilities | 20.802 M | 20.734 M | 25.252 M | 22.576 M | 18.507 M | 22.939 M | 25.292 M | |
| Accounts Payable | 9.885 M | 3.762 M | 4.835 M | 1.144 M | 3.635 M | 3.393 M | 7.803 M | |
| Other liabilities | 354.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 435.000 K | 410.000 K | 1.489 M | 1.561 M | 1.626 M | 1.701 M | 1.778 M | |
| Long term debt | 23.548 M | 23.587 M | 28.338 M | 27.916 M | 27.475 M | 27.023 M | 26.560 M | |
| Other liabilities | 354.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 266.254 M | 240.288 M | 209.061 M | 177.978 M | 151.899 M | 119.375 M | 88.211 M | |
| Common stock | 57.280 M | 57.386 M | 57.447 M | 57.486 M | 57.716 M | 57.795 M | 57.853 M | |
| Retained earnings | -332.027 M | -361.116 M | -394.842 M | -429.137 M | -457.981 M | -493.025 M | -525.979 M |